Basit öğe kaydını göster

Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607

dc.contributor.authorBreeman, Wout A. P.
dc.contributor.authorOcak, Meltem
dc.contributor.authorSosabowski, Jane K.
dc.contributor.authorReubi, Jean Claude
dc.contributor.authorDecristoforo, Clemens
dc.contributor.authorHelbok, Anna
dc.contributor.authorRangger, Christine
dc.contributor.authorPeitl, Petra Kolenc
dc.contributor.authorNock, Berthold A.
dc.contributor.authorMorelli, Giancarlo
dc.contributor.authorEek, Annemarie
dc.date.accessioned2021-03-06T10:07:59Z
dc.date.available2021-03-06T10:07:59Z
dc.date.issued2011
dc.identifier.citationOcak M., Helbok A., Rangger C., Peitl P. K. , Nock B. A. , Morelli G., Eek A., Sosabowski J. K. , Breeman W. A. P. , Reubi J. C. , et al., "Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607", EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, cilt.38, ss.1426-1435, 2011
dc.identifier.issn1619-7070
dc.identifier.otherav_e8df7b4c-1e63-47dc-938c-a1c088694113
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/153032
dc.identifier.urihttps://doi.org/10.1007/s00259-011-1818-9
dc.description.abstractStability of radiolabelled cholecystokinin 2 (CCK2) receptor targeting peptides has been a major limitation in the use of such radiopharmaceuticals especially for targeted radionuclide therapy applications, e.g. for treatment of medullary thyroid carcinoma (MTC). The purpose of this study was to compare the in vitro stability of a series of peptides binding to the CCK2 receptor [selected as part of the COST Action on Targeted Radionuclide Therapy (BM0607)] and to identify major cleavage sites.
dc.language.isoeng
dc.subjectNükleer Tıp
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectRADYOLOJİ, NÜKLEER TIP ve MEDİKAL GÖRÜNTÜLEME
dc.titleComparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607
dc.typeMakale
dc.relation.journalEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
dc.contributor.departmentMedical University of Innsbruck , ,
dc.identifier.volume38
dc.identifier.issue8
dc.identifier.startpage1426
dc.identifier.endpage1435
dc.contributor.firstauthorID201477


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster